Alberto P
Division d'oncologie, hôpital cantonal universitaire, Genève, Suisse.
Bull Cancer. 1995;82 Suppl 1:3s-8s.
The cytotoxic activity of cancer chemotherapy is related to the dose and to the amount of drug delivered per time unit. The significance of time in the effectiveness of a treatment program is frequently overlooked. The term of dose intensity (DI) is used to define the drug dose delivered per time unit and is expressed as mg/m2 per week. A delay in the sequence of treatment cycles decreases the DI in the same proportion as a reduction of dose. Average relative DI corresponds to the mean DI of combined agents and is expressed as a fraction of a similar combination selected as a standard. DI is useful to compare the dose actually received with the prescribed dose. The relation of DI with tumor response or survival has not been fully demonstrated. A threshold DI level for therapeutic activity is evident. Above this threshold, a linear relationship of DI and effectiveness is not obvious, particularly regarding high-dose chemotherapy. The term of DI is more useful in its principle than in the significance of its calculated value.
癌症化疗的细胞毒性活性与剂量以及每单位时间输送的药物量有关。时间在治疗方案有效性中的重要性常常被忽视。剂量强度(DI)这一术语用于定义每单位时间输送的药物剂量,以每周mg/m²表示。治疗周期顺序的延迟会使剂量强度按与剂量减少相同的比例降低。平均相对剂量强度对应于联合用药的平均剂量强度,并表示为选定作为标准的类似联合用药的分数。剂量强度有助于将实际接受的剂量与规定剂量进行比较。剂量强度与肿瘤反应或生存率之间的关系尚未得到充分证实。治疗活性的阈值剂量强度水平是明显的。高于此阈值,剂量强度与有效性之间的线性关系并不明显,尤其是在高剂量化疗方面。剂量强度这一术语在其原理上比在其计算值的意义上更有用。